Nonarteritic anterior ischemic optic neuropathy and tobacco smoking

被引:58
作者
Hayreh, Sohan Singh
Jonas, Jost B.
Zimmerman, M. Bridget
机构
[1] Univ Iowa, Coll Med, Dept Ophthalmol, Iowa City, IA 52242 USA
[2] Univ Iowa, Coll Med, Dept Visual Sci, Iowa City, IA 52242 USA
[3] Univ Heidelberg, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany
[4] Univ Heidelberg, Med Fac Mannheim, Hosp Eye, Mannheim, Germany
[5] Univ Iowa, Coll Publ Hlth, Dept Biostat, Iowa City, IA USA
关键词
D O I
10.1016/j.ophtha.2006.07.062
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To evaluate whether tobacco smoking may be a risk factor for development of nonarteritic anterior ischemic optic neuropathy (NA-AION). Design: Cohort study. Participants: Six hundred twenty-four consecutive patients with NA-AION who fulfilled our inclusion criteria. Methods: All patients provided a detailed ocular, medical, and smoking history, and underwent a comprehensive ophthalmic evaluation. For data analysis, patients were divided into current, former, and never smokers. The prevalence for current smoking in the NA-AION patients was compared to the corresponding race-, gender-, age-, and period-matched subgroup of the U.S. population. Main Outcome Measures: Association between NA-AION and tobacco smoking. Results: Of the 624 patients, 369 (59.1 %) were men, and mean (+/- standard deviation) age was 61.0 +/- 12.3 years. Of all the patients, 151 (24.2%) were current smokers, 160 (25.6%) former smokers, and 313 (50.2%) had never smoked. The prevalence of smoking in NA-AION patients was not significantly different from the prevalence in the period-matched U.S. population and the period matched Iowa population. In contrast, the prevalence of diabetes mellitus, ischemic heart disease, arterial hypertension, and cerebrovascular disease in NA-AION patients was significantly higher compared to the prevalence of these chronic conditions in the matched U.S. population (P < 0.0001). There was no significant difference in initial visual acuity (P = 0.97) or the amount of initial visual field loss (P = 0.31) among nonsmokers, former smokers, and current smokers. Current smokers had NA-AION in the first eye at a significantly younger age (57.8 +/- 11.7 years) than former smokers (64.0 +/- 10.2 years; P < 0.0001), and nonsmokers (60.4 +/- 13.5 years; P = 0.032). Comparison of the distribution of the time to develop NA-AION in the fellow eye showed no significant difference among the 3 groups (log-rank test P = 0.186). Conclusions: Our study showed no association between NA-AION and tobacco smoking.
引用
收藏
页码:804 / 809
页数:6
相关论文
共 23 条
[11]   SYSTEMIC-DISEASES ASSOCIATED WITH NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY [J].
HAYREH, SS ;
JOOS, KM ;
PODHAJSKY, PA ;
LONG, CR .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1994, 118 (06) :766-780
[12]   Nonarteritic anterior ischemic optic neuropathy: Time of onset of visual loss [J].
Hayreh, SS ;
Podhajsky, PA ;
Zimmerman, B .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1997, 124 (05) :641-647
[13]   NOCTURNAL ARTERIAL-HYPOTENSION AND ITS ROLE IN OPTIC-NERVE HEAD AND OCULAR ISCHEMIC DISORDERS [J].
HAYREH, SS ;
ZIMMERMAN, MB ;
PODHAJSKY, P ;
ALWARD, WLM .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1994, 117 (05) :603-624
[14]   Risk factors in AION [J].
Hayreh, SS .
OPHTHALMOLOGY, 2001, 108 (10) :1717-1718
[15]  
JOHNSON LN, 1994, OPHTHALMOLOGY, V101, P1322
[16]  
Moro F, 1989, Metab Pediatr Syst Ophthalmol (1985), V12, P46
[17]  
National Center for Health Statistics, 2005, 2005 CHARTB TRENDS H
[18]   The fellow eye in NAION: Report from the ischemic optic neuropathy decompression trial follow-up study [J].
Newman, NJ ;
Scherer, R ;
Langenberg, P ;
Kelman, S ;
Feldon, S ;
Kaufman, D ;
Dickersin, K .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2002, 134 (03) :317-328
[19]   Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy [J].
Salomon, O ;
Huna-Baron, R ;
Kurtz, S ;
Steinberg, DM ;
Moisseiev, J ;
Rosenberg, N ;
Yassur, I ;
Vidne, O ;
Zivelin, A ;
Gitel, S ;
Davidson, J ;
Ravid, B ;
Seligsohn, U .
OPHTHALMOLOGY, 1999, 106 (04) :739-742
[20]  
SCHAUMBERG DA, 1994, OPHTHALMOLOGY, V101, P1765